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Abstract: Timing of breast development (or thelarche) and its endogenous and exogenous
determinants may underlie global variation in breast cancer incidence. The study objectives were to
characterize endogenous estrogen levels and bisphenol A (BPA) exposure using a migrant study of
adolescent girls and test whether concentrations explained differences in thelarche by birthplace and
growth environment. Estrogen metabolites (EM) and BPA-glucuronide (BPA-G) were quantified in
urine spot samples using liquid chromatography tandem mass spectrometry (LC-MS/MS) from a
cross-sectional study of Bangladeshi, first- and second-generation Bangladeshi migrants to the UK, and
white British girls aged 5–16 years (n= 348). Thelarche status at the time of interview was self-reported
and defined equivalent to Tanner Stage ≥2. We compared geometric means (and 95% confidence
interval (CIs)) of EM and BPA-G using linear regression and assessed whether EM and BPA-G
explained any of the association between exposure to the UK and the age at thelarche using hazard
ratios and 95% confidence intervals. Average EM decreased with exposure to the UK, whereas BPA-G
increased and was significantly higher among white British (0.007 ng/mL, 95% CI: 0.0024–0.0217)
and second-generation British-Bangladeshi girls (0.009 ng/mL, 95% CI: 0.0040–0.0187) compared to
Bangladeshi girls (0.002 ng/mL, 95% CI: 0.0018–0.0034). Two of four EM ratios (16-pathway/parent
and parent/all pathways) were significantly associated with thelarche. The relationship between
exposure to the UK and thelarche did not change appreciably after adding EM and BPA-G to the
models. While BPA-G is often considered a ubiquitous exposure, our findings suggest it can vary
based on birthplace and growth environment, with increasing levels for girls who were born in or
moved to the UK. Our study did not provide statistically significant evidence that BPA-G or EM
concentrations explained earlier thelarche among girls who were born or raised in the UK.
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1. Introduction
Breast cancer incidence varies widely by country, with some of the highest rates in Western Europe
and lowest in Asia [1]. For example, the age-standardized breast cancer incidence rates in 2018 were
nearly six times higher in the United Kingdom (UK) (93.6 per 1,000,000) than in Bangladesh (17.0 per
1,000,000) [2]. Several epidemiological studies have focused on the role of endogenous hormone levels
and breast cancer risk, and have used age at menarche as a proxy for the first dose of cumulative lifetime
estrogen levels. However, other pubertal milestones, such as timing of onset of breast development
(thelarche), which occurs before menarche, may be important indicators of estrogenic activity. The
time period between thelarche and menarche may also be relevant for breast cancer risk because the
length of time between these two milestones may indicate a sensitive time period when individuals are
more susceptible to exposures to exogenous estrogenic chemicals. During puberty, the breast contains
the highest number and greatest proliferative activity of the terminal duct lobular units [3], the most
common site of ductal carcinoma [4]. Thus, early puberty, either as a proxy of endogenous exposure
dose or a longer sensitive window to exogenous factors, may have direct or indirect effects on breast
cancer risk later in life.
One hypothesized driver of earlier pubertal timing is exogenous exposure to hormonally active
agents, commonly referred to as endocrine disruptors. Bisphenol-A (BPA) is one such agent that is
thought to be ubiquitous in industrialized settings through its use in water bottles, food liners, and
drinking water pipes, but relatively unknown in low-middle income countries [5]. In Bangladesh,
consumption of bottled drinks has increased, potentially presenting an important source of BPA
exposure [6,7]. Bangladesh was also the first country in the world to ban plastic bags, thus the level
of exposure is unclear. Animal models suggest BPA demonstrates estrogenic activity [8], accelerates
pubertal onset [9], and increases mammary cancer risk [10]. However, epidemiological evidence
between BPA and puberty has been mixed [11]. Nevertheless, the World Health Organization
commissioned a report in 2012 on endocrine-disrupting chemicals and recommended research should
investigate whether early-life exposures are associated with changes in the timing of pubertal events [12].
Historically, studies of migrant populations have enabled examination of differences in
environmental and social factors associated with breast cancer risk [13]. A recent example by
Houghton et al. (2014) used a migrant study of British-Bangladeshi girls (named the Adolescence
among Bangladeshi and British Youth project, or ABBY) to test whether the growth environment
and/or ethnicity were associated with age and the tempo of pubertal milestones [14]. This population
is unique in that 95% of Bangladeshi migrants to the UK come from the Sylhet region, in the northeast
of the country, and tend to be similar ethnically and socioeconomically, providing a sample in which
to contrast environmental and social exposures [15]. Houghton et al. (2014) found that while age
at menarche was similar between groups, thelarche occurred between 1 to 2 years earlier among
British-Bangladeshi and white British girls, compared to Bangladeshi girls still living in their home
country. While differences in body mass index (BMI) between the groups partially explained this effect,
much of the difference was left unexplained, suggesting there could be other social or environmental
exposures driving the observed earlier thelarche.
The first objective of this study then was to assess the relationship between birthplace and growth
environment and both endogenous estrogen levels and exogenous BPA exposure within the same
cohort of British-Bangladeshi girls. The second objective was to test whether estrogen and BPA
concentrations could explain any of the association between exposure to the UK growth environment
(migrant scale) and thelarche previously reported [14]. Given the widespread exposure to endocrine
disruptors and the concern surrounding early breast development [12] and its potential association
with breast cancer later in life [16], this study represents an important step towards characterizing the
patterning of exogenous exposures and endogenous hormones during adolescence, and their impact
on pubertal events.
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2. Materials and Methods
2.1. Data Source
This analysis was conducted using ABBY data, a cross-sectional study of Bangladeshi, Bangladeshi
migrants to the UK, and white British girls aged 5–16 years of age (n = 469), details of which are
published elsewhere [15]. Briefly, girls were recruited from schools in London, England and Sylhet city,
Bangladesh from September 2009 to April 2011. After obtaining written consent from parents and
verbal assent from girls, researchers interviewed participants in person and collected anthropometric
measurements and urine samples. The ABBY project received IRB approval from Department of
Anthropology, Durham University Ethics Committee and the Sylhet M.A.G Osmani Medical College.
Additional approval for the current analysis was obtained from the Columbia University Medical
Center’s IRB (IRB-AAAS0007).
2.2. Measures
Migrant scale: Participants were classified according to their birthplace, their parents’ birthplace,
and self-reported ethnicity into the following categories: (1) Bangladeshi (those who were born and
reside in Bangladesh), (2) first-generation British-Bangladeshi (those born in Bangladesh but residing
in the UK), (3) second-generation British-Bangladeshi (those born in the UK to parents who emigrated
from Bangladesh), and (4) white British (those who were born in the UK to parents of white British
ethnicity). This scale captures increasing exposure to the UK environment, a proxy for a range of social
and environmental exposures.
Outcome: Thelarche status was assessed based on self-reporting using a modified version of
the pubertal development scale (PDS), and was defined as the PDS equivalent to Tanner Stage 2 or
higher [17,18]. Due to the cross-sectional nature of the data, thelarche was categorized as yes/no based
on whether or not it had occurred at the age of interview.
Urine Sample Collection: Urine spot samples were provided by UK and Bangladeshi participants
between 9:00 and 16:00 h and placed directly on ice. The urine was aliquoted and stored at 20 ◦C.
UK samples could be transported on ice to a local hospital for processing and temporary storage until
samples were transferred to Durham University. Samples from Bangladesh were transported on ice to
Sylhet M.A.G Osmani Medical College, where they were aliquoted and stored at −20 ◦C until being
shipped on dry ice to the UK. All UK and Bangladesh urine samples were shipped on dry ice to a
National Cancer Institute biorepository in the USA and then to the analytical lab.
Estrogen Metabolites: The Cancer Research Technology Program, Frederick National Laboratory
for Cancer Research conducted liquid chromatography tandem mass spectrometry (LC-MS/MS) on
0.5 mL of urine to measure 15 estrogens and estrogen metabolites (referred to collectively as EM). Details
of this method have been published previously [19,20]. Briefly, conjugated (glucuronide and sulfate)
EMs were hydrolyzed enzymatically and then measured together with unconjugated metabolites. EMs
included parent estrogens (estrone and estradiol), 2 and 4-methylated and unmethylated catechols,
and 16-hydroxylated metabolites. All coefficients of variation were below, or equal to, 3% for each
estrogen using internal repeat quality control samples.
Similar to previous studies, we examined EM in four groupings: (i) all EM combined, (ii) parent
estrogens only (estrone and estradiol), (iii) the 2-, 4-, and 16-pathways, and (iv) ratios of those
pathways [21]. The 2-pathway included 2-Hydroxyestrone, 2-Hydroxyestradiol, 2-Methoxyestrone,
2-Methoxyestradiol, 2-Hydroxyestrone-3-methyl ether; the 4-pathways included 4-Hydroxyestrone,
4-Methoxyestrone, 4-Methoxyestradiol; and the 16-pathways included 16α-Hydroxyestrone, Estriol,
17-Epiestriol, 16-Ketoestradiol, and 16-Epiestriol. The four ratios we examined were the 2-pathway to
parent, 4-pathway to parent, 16-pathway to parent, and parent to 2-, 4-, 6-pathway.
Bisphenol-A: The same urine samples were used to estimate BPA exposure. The urine assay
for BPA and BPA-G, the major conjugate excreted in urine, has demonstrated good reproducibility
(Coefficient of Variation = 6.7%; Intraclass Correlation Coefficient = 99.5%, meaning there was low
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variation and high correlation between samples) [20], and is generally preferred over serum or plasma,
due to the poor detectability in blood and potential contamination from blood collection materials [22].
In this study, collection tubes were known to be BPA-free. Since BPA is extensively metabolized to
BPA-G and excreted, we focused on the conjugated form (BPA-G) because it avoids the potential for
false values from background contamination. BPA-G values below the limit of detection (n = 67) were
replaced as 0.01 ng/mL (the limit of detection). All EM and BPA-G values were divided by creatinine
to correct for urinary dilution, log2-transformed to account for the skewed distribution, and added to
models as continuous variables. We used log-base 2, rather than traditional log-base 10, to improve
interpretability since the results can be interpreted as the effect per doubling of the hormone. Creatinine
was measured by PPD© using an enzymatic colorimetric assay; all CVs were below 2%.
Other variables: At the time of urine collection, participant age was recorded and anthropometric
measurements, including height, weight, and waist circumference were taken while the participant
was clothed but without shoes. BMI was calculated in kg/m2.
Missing data: Of the 348 girls with urine samples, 22 (6.3%) were missing data on whether
thelarche had occurred, 4 (1.6%) were missing age at urine sample collection, 39 (11.2%) were missing
information to calculate BMI, and 24 (6.9%) were missing waist circumference. Additionally, 11% were
missing BPA-G as a result of sample volume constraints. In order to explore the potential for selection
bias, we examined differences between girls with and without urine samples, and between girls with
and without BPA-G. Girls who did not provide urine were more likely to be Bangladeshi in Sylhet or
to have a higher BMI (Appendix A Table A1). No significant differences were found between girls with
BPA-G measurements and the total sample. The final study population included 348 girls.
2.3. Statistical Analysis
To characterize differences in EM and BPA by migrant scale (objective 1), we estimated differences
in the geometric mean and 95% confidence interval (CI) of urinary EM and BPA-G concentrations by the
migrant scale using linear regression. Each of the 11 EMs and BPA-Gs served as the dependent variables
and were modeled separately with the migrant scale as the primary predictor. Since age and BMI are
strongly related to estrogen production and there were known differences in age and BMI between
groups, we adjusted all EM models by age and BMI. Regression coefficients were back-transformed for
presentation in the tables. In order to assess the impact of menstrual cycle day on urine collection, we
performed an additional sensitivity analysis where we removed postmenarche girls (n = 72) from the
models and compared results to the model with all girls included.
To test whether estrogen and BPA explained any of the associations between migrant scale and
thelarche, we assessed whether the effect of migrant scale on thelarche changed after adjusting for
EM or BPA-G by examining the percentage change in the beta coefficient. We used Weibull regression
models, a parametric survival analysis [23], to account for both left censoring (for participants who
reached thelarche before enrollment into the study) and right censoring (for participants who had not
yet reached thelarche). More information on this method and how it compares with traditional Cox
models can be found in Houghton et al. (2014) [14]. We estimated hazard ratios and 95% confidence
intervals, interpreted as the risk of reaching thelarche at a given age.
Statistical significance for all analyses was defined as p < 0.05. We used SAS 9.4 (Cary, NC, USA)
for all analyses, except for the Weibull regression, which was conducted in STATA Version 15.0 (STATA
Corporation, College Station, TX, USA).
3. Results
3.1. Sample Characterististics
The study population included 161 Bangladeshi, 33 first-generation British-Bangladeshi, 114
second-generation British-Bangladeshi, and 40 white British girls, with an average age of 9.7, 11.5,
10.1, and 9.9 years, respectively (Table 1). Bangladeshi girls had the lowest average BMI compared
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with other groups, and the lowest average creatinine excretion (Table 1). Consistent with the age
distributions of each group, a greater proportion of first-generation British-Bangladeshi girls in the
sample had already reached menarche (48%), compared to 24% and 27% among the Bangladeshi and
second-generation British-Bangladeshi girls, respectively, and 13% among white British girls.
Table 1. Characteristics of the study sample of British and Bangladeshi girls 5–16 years of age with
urine samples, Adolescence among Bangladeshi and British Youth (ABBY) Project (n = 348).
Characteristics
Migrant Scale
Total
Bangladeshi FirstGeneration
Second
Generation
White
British
N 161 33 114 40 348
Age in years at sample
collection, mean (std) 9.7 (3.0) 11.5 (3.2) 10.1 (2.7) 9.9 (2.6) 10.0 (2.9)
Body Mass Index, kg/m2,
mean (std)
16.6 (3.5) 20.2 (4.6) 18.7 (3.7) 20.0 (3.7) 18.0 (3.9)
Creatinine, ng/mL, mean (std) 91 (53.9) 130 (120.4) 166 (80.6) 147 (80.3) 126 (81.7)
Included in BPA assay, n (%) 150 (93%) 27 (82%) 105 (92%) 26 (65%) 308 (89%)
Pubertal events
Menarche, % 24% 48% 27% 13% 26%
Thelarche, % 39% 76% 56% 74% 52%
Pubarche, % 26% 41% 40% 43% 34%
3.2. EM
EMs were detected among all study participants. The sum of all EMs combined ranged from 8.6
to 14,719 ng/mL. Second-generation British-Bangladeshi and white British girls had significantly lower
levels of 2-pathway (0.06 (95% CI: 0.03, 0.13) and 0.05 (95% CI: 0.02, 0.13), respectively) and 4-pathway
(0.01 (95% CI: 0.00, 0.02) and 0.01 (95% CI: 0.00, 0.02), respectively) EMs compared to Bangladeshi
girls (2-pathway = 0.08 (95% CI: 0.05, 0.13), 4-pathway = 0.01 (95% CI: 0.01–0.02)). Second-generation
British-Bangladeshi also had several significantly different EM ratios than Bangladeshi girls, including
the ratio of 2-pathway to parent, 4-pathway to parent, 16-pathway to parent, and parent to the 2-, 4-,
16-pathway. In our sensitivity analysis where we removed girls who had reached menarche, the point
estimates were similar but no longer significant.
3.3. BPA-G
BPA-G was detected in nearly 80% of the total sample, with urine concentrations ranging from
0.0396 to 69.8 ng/mL. Bangladeshi and first-generation British-Bangladeshi girls were more likely to have
concentrations below the limit of detection (34% and 22%, respectively) compared to second-generation
British-Bangladeshi (4%) or white British girls (15%). BPA-G concentrations increased significantly
(p < 0.0001 for trend) with duration of time in the UK, and were nearly 2 times greater in white British
compared with Bangladeshi girls (Table 2). White British (0.007 ng/mL, 95% CI: 0.0024–0.0217) and
second-generation British-Bangladeshi girls (0.009 ng/mL, 95% CI: 0.0040–0.0187) had significantly
higher BPA-G than Bangladeshi girls (0.002 ng/mL, 95% CI: 0.0018–0.0034).
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Table 2. Mean concentration of urinary estrogen metabolites (ng/mg creatinine) and Bisphenol-A-glucuronide (ng/mg creatinine) by migrant scale among British and
Bangladeshi girls 5–16 years of age, ABBY Project.
Estrogen Metabolites a,b (EMs)
(n = 300)
Migrant Scale c
Bangladeshi First Generation Second Generation White British
Trend p-ValueGeometric Mean
and 95% CI p-Value
Geometric Mean
and 95% CI p-Value
Geometric Mean
and 95% CI p-Value
Geometric Mean
and 95% CI p-Value
All EM combined 0.18 (0.10–0.30) REF 0.15 (0.06–0.38) 0.38 0.15 (0.07–0.32) 0.11 0.12 (0.05–0.30) 0.05 0.03
Parent estrogens 0.02 (0.01–0.03) REF 0.01 (0.00–0.04) 0.37 0.01 (0.01–0.03) 0.47 0.01 (0.00–0.03) 0.10 0.16
Pathways
2-Hydroxylation pathway 0.08 (0.05–0.13) REF 0.07 (0.03–0.16) 0.35 0.06 (0.03–0.13) 0.05 0.05 (0.02–0.13) 0.03 0.01
4-Hydroxylation pathway 0.01 (0.01–0.02) REF 0.01 (0.00–0.02) 0.36 0.01 (0.00–0.02) 0.03 0.01 (0.00–0.02) 0.04 0.01
16-Hydroxlation pathway 0.09 (0.05–0.15) REF 0.08 (0.03–0.20) 0.49 0.07 (0.03–0.16) 0.09 0.06 (0.03–0.16) 0.07 0.03
Ratios
2-Pathway/Parent estrogens 5.20 (4.06–6.67) REF 5.35 (3.47–8.24) 0.77 4.54 (3.15–6.54) 0.02 5.05 (3.30–7.72) 0.74 0.10
4-Pathway/Parent estrogens 0.75 (0.57–0.98) REF 0.77 (0.49–1.23) 0.75 0.64 (0.44–0.95) 0.02 0.74 (0.47–1.16) 0.90 0.11
16-Pathway/Parent estrogens 6.00 (4.77–7.54) REF 6.40 (4.30–9.53) 0.45 5.37 (3.83–7.52) 0.04 6.03 (4.08–8.92) 0.94 0.20
Parent estrogens/2-, 4-,
16-Pathways 0.08 (0.07–0.10) REF 0.08 (0.05–0.12) 0.61 0.09 (0.07–0.13) 0.02 0.08 (0.06–0.12) 0.95 0.13
BPA-G Analysis (n = 308)
BPA-G 0.002(0.0018–0.0034) REF
0.005
(0.0016–0.0142) 0.148
0.009
(0.0040–0.0187) <0.01
0.007
(0.0024–0.0217) <0.01 <0.01
a All values as standardized by creatinine, mean values are from linear regression analyses and are back-transformed from log-base 2. b Estrogen concentrations are adjusted for age and
body mass index (BMI). c We tested the effect of migrant scale as a categorical variable and as an ordinal variable. In both cases, Bangladeshi was the reference category.
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3.4. Thelarche
The parent EMs, pathways, and sum of all EMs appeared to be inversely, but not significantly,
associated with the onset of thelarche. Among the four ratios of pathways and parents, the 16-pathway
to parent ratio, and the parent to 2-, 4-, and 16-pathway (combined) were significantly associated with
thelarche (Table 3). The 16-pathway to parent ratio was associated with a 32% reduction in the onset of
thelarche (HR = 0.68, 95% CI: 0.48–0.95). Conversely, the parent to the combined 2-,4-,16- pathway ratio
was associated with a 44% increase in thelarche (HR = 1.44, 95% CI: 1.03–2.01). BPA-G concentrations
appeared positively associated with onset of thelarche, but the HR was not statistically significant
(HR = 1.04, 95% CI: 0.97–1.11).
Table 3. Hazard Ratio (HR) and 95% confidence interval for onset of thelarche by estrogens and BPA
among British and Bangladeshi girls 5–16 years of age, ABBY Project.
Estrogen Metabolites a,b (n = 300) Hazard Ratio Lower 95% CI Upper 95% CI
Total 0.92 0.81 1.06
Parent estrogens 0.97 0.86 1.09
Pathways
2-Hydroxylation pathway 0.90 0.79 1.04
4-Hydroxylation pathway 0.92 0.80 1.07
16-Hydroxlation pathway 0.91 0.75 1.10
Ratios
2-Pathway/Parent estrogens 0.77 0.57 1.03
4-Pathway/Parent estrogens 0.87 0.66 1.15
16-Pathway/Parent estrogens 0.68 0.48 0.95
Parent estrogens/2-, 4-, 16-Pathways 1.44 1.03 2.01
BPA-G Analysis a,c (n = 299)
BPA-G 1.04 0.97 1.11
a All the EMs and BPA-Gs were included in the models as continuous variables. b Estrogen analysis excludes those
missing information on thelarche, age, and BMI (n = 48). c BPA-G analysis excludes those missing information on
thelarche and age (n = 9).
Adding the sum or individual EM or BPA-G concentrations to the model assessing the relationship
between migrant scale and thelarche had minimal effects on the association (Table 4). For example,
after adding the sum of all EMs to the model with migrant scale and BMI, the HR for thelarche changed
from 1.76 to 1.72, from 1.23 to 1.20, and from 2.20 to 2.12 among first-generation, second-generation,
and white British girls compared to Bangladeshi girls (Model 2 vs. Model 3). A similar lack of effect
was seen with the other EM (data not shown). Likewise, when adding BPA-G concentrations to the
model with migrant scale, the HR for thelarche changed from 1.72 to 1.78, from 1.18 to 1.24, and from
1.85 to 1.93 among first-generation, second-generation, and white British girls compared to Bangladeshi
girls (Table 5, Model 6 vs. Model 5).
Table 4. Effect of EM on the association between migrant scale and risk of thelarche among British and
Bangladeshi girls 5–16 years of age, ABBY Project, includes sample with EM (n = 300).
Migrant Scale
Model 1 a Model 2 a Model 3 a
Crude Model 1+ BMI Model 2 + Total EM
HR 95% CI HR 95% CI HR 95% CI
Bangladeshi REF REF REF
First-generation 2.47 1.12–5.44 1.76 0.80–3.85 1.72 0.78–3.81
Second-generation 1.58 1.03–2.44 1.23 0.77–1.98 1.20 0.75–1.94
White British 2.92 1.59–5.35 2.20 1.15–4.21 2.12 1.09–4.10
a Analysis excludes those missing information on thelarche, age, or BMI (n = 48).
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Table 5. Effect of BPA on the association between migrant scale and risk of thelarche among British and
Bangladeshi girls 5–16 years of age, ABBY Project, includes sample with BPA assay (n = 277).
Migrant Scale
Model 4 a Model 5 a Model 6 a Model 7 a
Crude Model 4 + BMI Model 5+ BPA Model 6 + Total EM
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
Bangladeshi REF REF REF REF
First-generation 2.42 1.10–5.33 1.72 0.78–3.79 1.78 0.8–3.98 1.75 0.77–3.93
Second-generation 1.5 0.99–2.29 1.18 0.73–1.9 1.24 0.74–2.06 1.2 0.71–2.02
White British 2.65 1.38–5.11 1.85 0.89–3.84 1.93 0.91–4.09 1.85 0.86–3.95
a Analysis excludes those missing information on thelarche, age, BMI, and BPA (n = 71).
4. Discussion
In this study of adolescent girls in Bangladesh and the UK, we found there were differences in the
urinary concentrations of EM and BPA-G by place of birth and growth environment. In particular,
urinary BPA-G concentrations were higher among those living in the UK for longer periods (whether
native-born or migrant), while EM concentrations were lower. Our findings represent an important
step towards simultaneously characterizing endogenous estrogen hormones and exogenous BPA
exposure among adolescents in Bangladesh, an area where little information about BPA exposure is
known. While we found some differences in thelarche by EM pathway or route of metabolism, our
study did not provide evidence to suggest that variation in EM or BPA-G explained differences in
thelarche between groups reported in our prior publication [14].
Recent reviews have highlighted the paucity of information on BPA exposure from low-middle
income countries, where packaged foods and beverages containing BPA have become increasingly
common but regulation has lagged behind that of developed countries [5]. One of the few studies
documenting urinary BPA concentrations in Asia identified detectable levels in 94.3% of samples and a
geometric mean concentration of 1.20 ng/mL based on an LC-MS/MS assay. The authors reported a
high degree of variation among the seven southeast Asian and Middle Eastern countries included in
the study (China, India, Japan, Korea, Kuwait, Malaysia, and Vietnam), with the highest concentrations
in Kuwait (3.05 ng/mL) and lowest in Japan (0.95 ng/mL) [24]. In the US population, Calafat et al.
report that 92.6% of adults had detectable BPA levels in the 2003–2004 National Health and Nutrition
Examination Survey (NHANES), with a geometric mean of 2.6 µg/L [25]. A subsequent study of
adolescents aged 12–19 years with pooled NHANES data from 2003–2010 found a similar mean BPA
exposure (2.64 ng/mL) to the adult population [26]. While variation in urine sampling, assays, and
form of BPA (e.g., BPA vs. BPA-G) makes a direct comparison difficult, we found BPA-G concentrations
were detectable in 80% of our sample, with lower levels (66%) among Bangladeshi girls. Mean BPA-G
concentrations were also significantly lower among girls from Bangladesh compared to those in the
UK, indicating that environmental exposure to BPA-G varied meaningfully between countries. BPA
exposure in Bangladesh may be lower than the UK as a result of dietary behaviors, as has been
shown in other populations where there is less use of plastic bottles and frozen meals [27] or greater
country-wide regulations, such as a ban on plastic bags that went into effect in Bangladesh in 2002 [28].
Conversely, we found that EM levels decreased with duration of time in the UK, although not
significantly. This runs counter to evidence from adult studies where urinary estrogen levels tend to
be higher in Western countries. For example, total estrogen and EMs were three times higher among
Asian-American women in the US (Chinese, Japanese, and Filipino) than in Shanghai-based Chinese
women [29]. We also found that specific EM ratios were significantly associated with the timing of
thelarche. In particular, the 16-pathway to parent ratio was associated with an increased probability of
thelarche, as was the parent to the combined 2-, 4-, 16-pathway ratio. This might indicate that higher
endogenous levels of parent estrogens, as opposed to their downstream pathways, play a role in breast
development. The 16-pathway to parent ratio has been implicated in previous studies of breast cancer,
increasing risk among premenopausal women by 61% [30]. Our findings suggest that the balance
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of parent and pathway estrogen metabolites are not only relevant later in life, but may also alter the
timing of pubertal events. Future studies of breast cancer risk should consider measuring estrogen
exposure during sensitive developmental windows across the life course.
Despite some differences in urinary concentrations of BPA and estrogens between the groups, our
study found limited evidence that these concentrations explained the association between exposure
to the UK environment and earlier thelarche. Evidence concerning the relationship between BPA
and pubertal outcomes has been mixed [11]. Several toxicological studies have reported that early
exposure to low doses of BPA altered the development of rodent mammary glands, which manifested
from the time of exposure and was exacerbated at puberty and beyond [31]. In mouse models, BPA
accelerates pubertal onset [9], shows estrogenic activity [4], and increases mammary cancer risk [10].
In a Chinese case-control study, serum BPA was higher in girls with precocious puberty compared
to controls [14]. Other cross-sectional studies with US girls have found no association with urinary
BPA and thelarche [15,16]. In 2003–2008, NHANES urinary BPA was not significantly associated with
age of menarche [17]. It may be that previous epidemiologic studies have not replicated the findings
from toxicological studies because they lack an adequate range in BPA exposure, were underpowered,
or did not fully capture long-term exposure based on urinary measures. If BPA is in fact not driving
thelarche, as these mixed findings could suggest, other established drivers of pubertal timing include
genetics, birth weight, stress, nutritional status, and other environmental exposures.
Our study has several limitations to note. First, the data were cross-sectional and thelarche,
estrogen, estrogen metabolites, and BPA were only assessed at one point in time. While intraclass
correlation coefficients for EMs are high, indicating good reproducibility [32], BPA varies greatly
over time within an individual [33]. We addressed left/right censoring of thelarche by using Weibull
regression models, which provide a valid estimate of the hazard of thelarche at a given age, but
reduce the statistical power of our analysis. Secondly, we did not collect detailed information on all
known drivers of estrogen, including sleep, and menstrual cycle day from girls who had reached
menarche and cannot account for these sources of variability in estrogen levels. We had crude dietary
pattern data, but not at the micronutrient level where we would expect to see effects on metabolism.
We also had data on medication taken in the previous two weeks, which was minimal (<20%), and
primarily pain killers. We also could not control for all potential sources of variability in urinary
concentration of BPA. For example, individual differences in metabolism, such as the activity of
glucuronosyl transferases or BPA conjugation, could affect the bioaccumulation of BPA-g in urine.
As a result, our biomarker could reflect different lengths of exposure time; however, there is no reason
to believe this would vary by migrant group. Our study design prioritized collecting data from a
population that had migrated, which allowed us to contrast exposure levels by place of birth and
growth environment, an important contribution to the literature. However, this resulted in a relatively
small study population, particularly among first-generation, British-Bangladeshi girls. This led to wide
confidence intervals around estimates and potentially underestimated differences in effects. Finally,
due to the school setting from where girls were recruited, thelarche was defined via self-reporting
rather than clinical examination. While outcome misclassification is possible, previous studies have
found good concordance between both self-report and physical examination, as well as with basal
hormone levels [34]. Unless there was systematic over- or under-reporting of thelarche by the migrant
group, any misclassifications would have attenuated results.
5. Conclusions
In response to growing concerns about early-life exposure to endocrine disruptors and pubertal
outcomes, we explored the relationship between BPA, estrogen metabolites, and thelarche in a unique,
cross-sectional migrant study of adolescent girls from the UK and Bangladesh. By contrasting
birthplace and growth environment between countries, we found a clear pattern of increasing BPA-G
and decreasing estrogen/estrogen metabolite concentrations with duration of time in the UK. We also
found that the onset of thelarche was associated with ratios of parent to pathway estrogen metabolites,
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particularly the 16-pathway, which has been implicated in breast cancer research. Ultimately, BPA-G
and estrogen did not explain earlier onset of thelarche in white British girls, which could indicate that
other environmental or social factors were at play, or that the current study was underpowered.
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Appendix A
Table A1. Characteristics of girls with and without urine samples.
Characteristics
No Urine Urine Total p-Value
N % N % N
Total 121 26% 348 74% 469
Migrant scale <0.01
Bangladeshi 30 16% 161 84% 191
First Generation 14 30% 33 70% 47
Second Generation 60 34% 114 66% 174
White British 17 30% 40 70% 57
Pubertal outcomes
Pubarche 26 19% 109 81% 135 0.27
Thelarche 42 20% 169 80% 211 0.44
Menarche 27 23% 88 77% 115 0.95
Mean (std) Mean (std)
Age, years 9.8 (2.9) 10.0 (2.9) 0.42
Waist Circumference (cm) 62.2 (10.7) 58.5 (10.3) <0.01
Body Mass Index, kg/m2 55.9 (359) 18.0 (3.9) 0.06
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